-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
InMed Pharmaceuticals Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2020 to Q3 2024.
- InMed Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $838K.
- InMed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $12.3M, a 164% increase from 2024.
- InMed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4.65M, a 56.4% decline from 2023.
- InMed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $10.7M, a 29.1% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)